Health Plan (7.4) 7.4

P-OPS 7 - Care Coordination Regarding Medication Safety

Submited by: Tom Goddard

The Basics

This standard requires that your organization promote medication safety for at-risk consumers by implementing mechanisms to address at least three areas:

  • Medication reconciliation at care transitions;
  • Knowledge of medications by members and their caregivers; and
  • Medication adherence. 
URAC defines "medication reconciliation" as "[t]he process of creating the most accurate list possible of all medications a patient is taking - including drug name, dosage, frequency, and route - and comparing that list against the physician's admission, transfer and/or discharge orders, with the goal of providing correct medications to the patient at all transition points."

Management Tips

You'll need a P&P on this one that defines your organization's criteria used to identify at-risk members. In addition, the P&P should outline strategies for promoting medication safety. The possible mechanisms and activities to demonstrate compliance with this standard include:

  • disease management activities that address caregiver knowledge of medication;
  • tracking medication adherence; and 
  • reimbursement for outsourced medication reconciliation, among many others.

Accreditation Tips

Desktop Review
For the desktop review phase of the accreditation process, you need submit only P&Ps that address, in sufficient detail, all elements of this standard.
Validation Review
During the onsite review, the reviewer will conduct staff interviews and examine the member-facing information regarding medication safety and adherence.

  • Health Plan (7.4) 7.4 / 02.19.2021

    P-OPS 12 - Breach Handling

    This standard outlines the requirements for your organization when a privacy breach is discovered. The process must include:Recording the date your organization knew or should have known of the breach;Notifying the privacy and security official(s);Determining whether a breach actually occurred;Once it's determined that a breach did, in fact, occur, Recording the date of the breach;Mitigating the c...

  • Health Plan (7.4) 7.4 / 02.19.2021

    P-OPS 11 - Oversight of Automated Review of Pharmacy Non-Certifications

    If your organization conducts automated review in connection with drug management, you must have written P&Ps that describe the oversight mechanism for such automated review. That oversight must be conducted by both a senior clinician and a clinical oversight body. That oversight body can be, but need not be, the P&T Committee.The oversight of automated review must be active and well-documented. O...

  • Health Plan (7.4) 7.4 / 02.19.2021

    P-OPS 10 - Economic Formulary Considerations

    In order to assure that cost issues do not supercede clinical issues, this standard prohibits consideration of economic factors of a medication before its safety efficacy, therapeutic appropriateness, and side effects have been established. Once those issues have been considered, it is appropriate to evaluate equivalent alternative medications and therapies in terms of their impact on health costs...